Colorectal Cancer

Colorectal Cancer News

GICS Oxaliplatin Has Few Benefits, High Toxicity in Rectal Cancer Long-term results from the French ACCORD 12 trial show that adding oxaliplatin to capecitabine plus radiotherapy does not improve survival in rectal cancer.
Medscape Medical News, January 31, 2012
GICS Long-Term Survival Benefits in Colon Cancer With Oxaliplatin A capecitabine/oxaliplatin regimen significantly improves survival in stage III colon cancer, compared with 5-fluorouracil/leucovorin, even 7 years after treatment.
Medscape Medical News, January 27, 2012

Risk Factors for Mortality After Colorectal Cancer Surgery Commentary on a study that aimed to identify risk factors for postoperative mortality after colorectal cancer surgery, published in November 2011 in Annals of Surgery.
Medscape General Surgery, January 18, 2012
Are Diabetes and Colorectal Cancer Risk Genetically Linked? Dr. Ali Torkamani reviews a recent paper suggesting a genetic link between type 2 diabetes and risk for colorectal cancer -- or possibly vice versa.
Medscape Genomic Medicine, January 3, 2012

A Randomized Colorectal Cancer Screening Intervention Trial
Journal of the American Board of Family Medicine, February 1, 2012
Cecal Intubation Rate During Colonoscopy in Sedated Patients
Journal of Gastroenterology and Hepatology, January 31, 2012
Fecal Occult Blood Testing When Colonoscopy is Limited
Journal of the National Cancer Institute, January 30, 2012
Laparoscopic Liver Resection for Colorectal Cancer Metastases
AccessMedicine from McGraw-Hill, January 13, 2012
Liver Metastases From Colorectal Cancer
Future Oncology, January 10, 2012